Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
941
Views
1
CrossRef citations to date
0
Altmetric
Influenza – Letter

Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years

J. Kevin Yina Global Medical Affairs, Sanofi, Singapore;b Faculty of Medicine and Health, The University of Sydney, NSW, AustraliaCorrespondence[email protected]
View further author information
,
Stephanie Pepinc Global Clinical Sciences, Sanofi, Lyon, FranceView further author information
,
Robertus van Aalstd Department of Modeling, Epidemiology and Data Science, Global Medical Affairs, Sanofi, Lyon, France;e Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA;f Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsView further author information
,
Matthew M. Loiaconog Global Medical Evidence Generation, Sanofi, Swiftwater, PA, USAView further author information
&
Sandrine I. Samsonh Global Medical Affairs, Sanofi, Lyon, FranceView further author information
Article: 2106749 | Published online: 01 Aug 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.